- Home
- OSUR vs GHI Comparison
OSUR vs GHI Comparison
Compare OSUR & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- GHI
- Stock Information
- Founded
- OSUR 2000
- GHI 1998
- Country
- OSUR United States
- GHI United States
- Employees
- OSUR N/A
- GHI N/A
- Industry
- OSUR Medical/Dental Instruments
- GHI Finance: Consumer Services
- Sector
- OSUR Health Care
- GHI Finance
- Exchange
- OSUR Nasdaq
- GHI Nasdaq
- Market Cap
- OSUR 248.3M
- GHI 285.3M
- IPO Year
- OSUR 1986
- GHI N/A
- Fundamental
- Price
- OSUR $3.10
- GHI $11.56
- Analyst Decision
- OSUR Hold
- GHI Strong Buy
- Analyst Count
- OSUR 2
- GHI 3
- Target Price
- OSUR $5.50
- GHI $16.50
- AVG Volume (30 Days)
- OSUR 682.8K
- GHI 35.8K
- Earning Date
- OSUR 05-07-2025
- GHI 05-07-2025
- Dividend Yield
- OSUR N/A
- GHI 12.18%
- EPS Growth
- OSUR N/A
- GHI N/A
- EPS
- OSUR N/A
- GHI 0.76
- Revenue
- OSUR $185,827,000.00
- GHI $32,275,700.00
- Revenue This Year
- OSUR N/A
- GHI $224.89
- Revenue Next Year
- OSUR $7.46
- GHI N/A
- P/E Ratio
- OSUR N/A
- GHI $15.99
- Revenue Growth
- OSUR N/A
- GHI N/A
- 52 Week Low
- OSUR $2.69
- GHI $10.12
- 52 Week High
- OSUR $6.35
- GHI $16.10
- Technical
- Relative Strength Index (RSI)
- OSUR 37.03
- GHI 33.70
- Support Level
- OSUR $3.34
- GHI $12.44
- Resistance Level
- OSUR $3.38
- GHI $12.36
- Average True Range (ATR)
- OSUR 0.14
- GHI 0.30
- MACD
- OSUR -0.02
- GHI -0.13
- Stochastic Oscillator
- OSUR 0.88
- GHI 0.66
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.